Antibodies against synthetic carboxy-terminal peptides distinguish H-ras and K-ras oncogene products p21
- 1 October 1987
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 103 (1) , 131-139
- https://doi.org/10.1016/0022-1759(87)90250-x
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiationCell, 1985
- Antibodies specific for amino acid 12 of the ras oncogene product inhibit GTP binding.Proceedings of the National Academy of Sciences, 1985
- Biochemical properties of a highly purified v-rasH p21 protein overproduced in Escherichia coli and inhibition of its activities by a monoclonal antibody.Molecular and Cellular Biology, 1985
- Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteinsNature, 1984
- Microinjection of the oncogene form of the human H-ras (t-24) protein results in rapid proliferation of quiescent cellsPublished by Elsevier ,1984
- Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutationsNature, 1983
- Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologueNature, 1983
- Nucleotide Sequence of the p21 Transforming Protein of Harvey Murine Sarcoma VirusScience, 1982
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976